Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia.

Zheng YS, Zhang H, Zhang XJ, Feng DD, Luo XQ, Zeng CW, Lin KY, Zhou H, Qu LH, Zhang P, Chen YQ.

Oncogene. 2012 Jan 5;31(1):80-92. doi: 10.1038/onc.2011.208. Epub 2011 Jun 6.

2.

Cell differentiation in acute myeloid leukemia.

Olsson I, Bergh G, Ehinger M, Gullberg U.

Eur J Haematol. 1996 Jul;57(1):1-16. Review.

PMID:
8698118
3.

miR signatures and the role of miRs in acute myeloid leukaemia.

Seca H, Almeida GM, Guimarães JE, Vasconcelos MH.

Eur J Cancer. 2010 Jun;46(9):1520-7. doi: 10.1016/j.ejca.2010.03.031. Epub 2010 Apr 21. Review.

PMID:
20413298
4.

Epigenetic mechanisms in acute myeloid leukemia.

Peters AH, Schwaller J.

Prog Drug Res. 2011;67:197-219. Review.

PMID:
21141731
5.

The pathological role and prognostic impact of miR-181 in acute myeloid leukemia.

Weng H, Lal K, Yang FF, Chen J.

Cancer Genet. 2015 May;208(5):225-9. doi: 10.1016/j.cancergen.2014.12.006. Epub 2015 Jan 7. Review.

6.

The role of microRNAs in normal and malignant hematopoiesis.

Vasilatou D, Papageorgiou S, Pappa V, Papageorgiou E, Dervenoulas J.

Eur J Haematol. 2010 Jan 1;84(1):1-16. doi: 10.1111/j.1600-0609.2009.01348.x. Epub 2009 Sep 10. Review.

PMID:
19744129
7.

The effect of anti-CD44 monoclonal antibodies on differentiation and proliferation of human acute myeloid leukemia cells.

Gadhoum Z, Delaunay J, Maquarre E, Durand L, Lancereaux V, Qi J, Robert-Lezenes J, Chomienne C, Smadja-Joffe F.

Leuk Lymphoma. 2004 Aug;45(8):1501-10. Review.

PMID:
15370200
8.

The prognostic and functional role of microRNAs in acute myeloid leukemia.

Marcucci G, Mrózek K, Radmacher MD, Garzon R, Bloomfield CD.

Blood. 2011 Jan 27;117(4):1121-9. doi: 10.1182/blood-2010-09-191312. Epub 2010 Nov 2. Review.

9.

MN1, a novel player in human AML.

Grosveld GC.

Blood Cells Mol Dis. 2007 Nov-Dec;39(3):336-9. Epub 2007 Aug 14. Review.

10.

CREB and leukemogenesis.

Cho EC, Mitton B, Sakamoto KM.

Crit Rev Oncog. 2011;16(1-2):37-46. Review.

11.

Discovering Small Molecules that Overcome Differentiation Arrest in Acute Myeloid Leukemia.

Sykes DB, Haynes MK, Waller A, Garcia M, Ursu O, Gouveia KE, Sklar L, Lewis TA, Dandapani S, Munoz B, Scadden DT, Palmer M, Schreiber SL.

Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-.
2013 Dec 15 [updated 2015 Feb 11].

12.

The molecular pathology of acute myeloid leukemia.

Licht JD, Sternberg DW.

Hematology Am Soc Hematol Educ Program. 2005:137-42. Review.

PMID:
16304371
13.

Why Is Progress in Acute Myeloid Leukemia So Slow?

Estey E.

Semin Hematol. 2015 Jul;52(3):243-8. doi: 10.1053/j.seminhematol.2015.03.007. Epub 2015 Mar 17. Review.

PMID:
26111472
14.

Mitochondrial dependency in progression of acute myeloid leukemia.

Basak NP, Banerjee S.

Mitochondrion. 2015 Mar;21:41-8. doi: 10.1016/j.mito.2015.01.006. Epub 2015 Jan 29. Review.

PMID:
25640960
15.

Epigenetic changes: a common theme in acute myelogenous leukemogenesis.

Gutierrez SE, Romero-Oliva FA.

J Hematol Oncol. 2013 Aug 13;6:57. doi: 10.1186/1756-8722-6-57. Review.

16.

Noncoding RNAs in Acute Myeloid Leukemia: From Key Regulators to Clinical Players.

Fatica A.

Scientifica (Cairo). 2012;2012:925758. doi: 10.6064/2012/925758. Epub 2012 Sep 18. Review.

Supplemental Content

Support Center